Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations
Brain Stimulation · 2023
DOI: 10.1016/j.brs.2023.02.006 ↗Kurz gefasst
Leserbrief in der Zeitschrift Brain Stimulation, 2023. Verfasst von Joline M Fan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, San Francisco, CA, USA; Weill Institute for Neurosciences, University of California, San Francisco…. Hauptthemen laut MEDLINE: Epilepsy, Deep Brain Stimulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NCATS NIH HHS.
Themen: Depression
Abstract (Originalsprache)
Direct electrical brain stimulation (DES) has been investigated for diverse neuropsychiatric indications, including mood disorders, obsessive compulsive disorder, and chronic pain [1]. DESmodulates neural activity of dysfunctional networks to achieve therapeutic effects [2]. Although chronic DES can reduce seizure frequency in people with epilepsy [2,3], its effectsdboth intended and unintendeddare not well established in people without epilepsy. Potential adverse effects of chronic DES include lowering the threshold for and eliciting epileptiform activity [4e6], e.g. afterdischarges, spontaneous discharges, or seizures. Compared to open-loop DES, newer closed-loop DES systems incorporate intracranial electroencephalography (iEEG) recordings, which enable monitoring for epileptiform activity. We report a case of epileptiform activity triggered by chronic closed-loop neurostimulation in a patient enrolled in a clinical trial for treatment-resistant major depressive disorder (trMDD). Our early experience with closed-loop DES provides unique insights into factors related to the emergence of epileptiform activity and the potential safety advantages of DES with concurrent iEEG for non-epilepsy conditions. A 29-year-old woman with trMDD and no known history of epilepsy enrolled in an ongoing multi-stage clinical trial for personalized closed-loop DES. She had failed a variety of oral agents, intensive psychotherapy, ketamine infusions, and transcranial magnetic stimulation. Multiple rounds of electroconvulsive therapy (ECT; 60 total treatments) previously provided a modest, transient benefit. She thus trialed personalized closed-loop DES, which continuously monitors neural activity intracranially and stimulates in response to detections of neural patterns that represent biomarkers of mood symptom state. Stage 1 of the clinical trial involved iEEG recording with subacute electrodes, inpatient stimulation-response mapping, and iEEG biomarker discovery. Ten depth electrodes were implanted with distal contacts in bilateral orbitofrontal cortex (OFC), subgenual cingulate (SGC), hippocampus, amygdala, and ventral capsule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of California, San Francisco, CA, USA; Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. Electronic address: Joline.Fan@ucsf.edu.
- Weill Institute for Neurosciences, University of California, San Francisco, CA, USA; Department of Neurosurgery, University of California, San Francisco, CA, USA.
- Department of Psychiatry, University of California, San Francisco, CA, USA.
- Weill Institute for Neurosciences, University of California, San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
- Weill Institute for Neurosciences, University of California, San Francisco, CA, USA; Department of Psychiatry, University of California, San Francisco, CA, USA.
- Department of Neurology, University of California, San Francisco, CA, USA; Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
Förderung
- NINDS NIH HHS
- NCATS NIH HHS
Zitieren
APA
Fan, J. M., Khambhati, A. N., Sellers, K. K., Stapper, N., Maya, D. A., Kunwar, E., Henderson, C., Sugrue, L. P., Scangos, K. W., Chang, E. F., Rao, V. R., & Krystal, A. D. (2023). Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations. Brain Stimulation. https://doi.org/10.1016/j.brs.2023.02.006
Vancouver
Fan JM, Khambhati AN, Sellers KK, Stapper N, Maya DA, Kunwar E, et al. Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations. Brain Stimulation. 2023. doi:10.1016/j.brs.2023.02.006
BibTeX
@article{Fan2023,
author = {Fan, Joline M and Khambhati, Ankit N and Sellers, Kristin K and Stapper, Noah and Maya, Daniela Astudillo and Kunwar, Elysha and Henderson, Catherine and Sugrue, Leo P and Scangos, Katherine W and Chang, Edward F and Rao, Vikram R and Krystal, Andrew D},
title = {Epileptiform discharges triggered with direct electrical stimulation for treatment-resistant depression: Factors that modulate risk and treatment considerations},
journal = {Brain Stimulation},
year = {2023},
doi = {10.1016/j.brs.2023.02.006}
}
EUVIMED